Health Catalyst Q2 top line up 60%; non-GAAP EBITDA negative

Health Catalyst (NASDAQ:HCAT) Q2 results:

Revenue: $36.8M (+60%); Technology: $20.1M (+88%); Professional Services: $16.7M (+36%).

Net loss: ($10.7M); non-GAAP EBITDA: ($5.7M).

Cash flow ops (6 mo.): ($13.6M) (+36%).

Q3 guidance: Revenue: $36.8M – 38.8M; non-GAAP EBITDA: ($11.2M – 9.2M).

2019 guidance: Revenue: $149.8M – 151.8M; non-GAAP EBITDA: ($31.7M – 29.7M).

Shares down 3% after hours.

Previously: Health Catalyst EPS beats by $0.11, beats on revenue (Aug. 22)

https://seekingalpha.com/news/3494181-health-catalyst-q2-top-line-60-percent-non-gaap-ebitda-negative